Lucid Diagnostics LUCD
NASDAQ LUCD
$0.85 -0.05 (-5.33%)
As of: Sep 9, 2026 · 1:47 PM EDT

Lucid Diagnostics (LUCD) EBIT Margin Growth (1y) (2022 - 2026)

Analysis

Lucid Diagnostics (LUCD) EBIT Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Natera 47.08 Bn 45.98 Bn 486.15 Mn 1,012.00
2 Labcorp Holdings 26.13 Bn 25.99 Bn 1.11 Bn 92.00
3 Quest Diagnostics 25.90 Bn 25.27 Bn 1.03 Bn -78.00
4 Guardant Health 21.89 Bn 20.84 Bn 219.03 Mn 731.00
5 Tempus AI 11.21 Bn 10.39 Bn 274.25 Mn -21.00
6 Caris Life Sciences 6.94 Bn 6.15 Bn 182.38 Mn 2,013.00
7 Sotera Health 5.22 Bn 4.86 Bn 177.96 Mn 97.00
8 BillionToOne 4.78 Bn 4.23 Bn 77.11 Mn 747.00
9 iRhythm Holdings 3.96 Bn 3.37 Bn 163.21 Mn 889.00
10 Lucid Diagnostics 155.47 Mn 122.07 Mn 55,000.00 12,545.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12,545.00
Mar 31, 2026 57,625.00
Dec 31, 2025 10,225.00
Sep 30, 2025 2,677.00
Jun 30, 2025 16,787.00
Mar 31, 2025 -42,997.00
Dec 31, 2024 6,742.00
Sep 30, 2024 42,342.00
Jun 30, 2024 613,881.00
Mar 31, 2024 213,197.00
Dec 31, 2023 1.23 Mn
Sep 30, 2023 1.75 Mn
Mar 31, 2023 328,250.00
Dec 31, 2022 -962,354.00
Sep 30, 2022 -1.57 Mn